Mersana Therapeutics, Inc.MRSNNASDAQ
LOADING
|||
EV to Sales: Discounted Valuation
Trending lower, below historical average, structural decline.
Left:
||||
Enterprise value to sales ratio
Latest
2.37
↓ 100% below average
Average (9y)
872.59
Historical baseline
Range
High:6959.13
Low:2.37
CAGR
-22.1%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | 2.37 | -32.0% |
| 2023 | 3.49 | -79.7% |
| 2022 | 17.16 | -99.8% |
| 2021 | 6959.13 | +312.3% |
| 2020 | 1688.03 | +36537.4% |
| 2019 | 4.61 | +42.1% |
| 2018 | 3.24 | -83.4% |
| 2017 | 19.56 | +240.4% |
| 2016 | 5.74 | -74.5% |
| 2015 | 22.53 | - |